SUBSCRIBE
SUBSCRIBE

Alliances

Business
Gentris Corporation And Shanghai Institute Sign MOU For Biomarker Collaboration
October 11, 2017
 · 
1 min read
Business
As Johnson & Johnson’s Animas Shuts Down, Insulet Eyes Its Customers
October 10, 2017
 · 
1 min read
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Business
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
October 10, 2017
 · 
3 min read
AbbVie Leaps Into the Land of Oncolytics With New Turnstone Biologics Tie-Up
Business
AbbVie Leaps Into the Land of Oncolytics With New Turnstone Biologics Tie-Up
October 10, 2017
 · 
2 min read
Business
Royal Philips Electronics N.V. Terminates Remote Servicing Deal With Digirad, Effective December 31
October 6, 2017
 · 
1 min read
Biotech Giant Amgen Bets $1.5 Billion on Bay Area CytomX's Cancer Drugs
Business
Biotech Giant Amgen Bets $1.5 Billion on Bay Area CytomX’s Cancer Drugs
October 4, 2017
 · 
2 min read
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
Business
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
October 3, 2017
 · 
2 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Business
Novartis AG Launches R&D Center on UC Berkeley’s Campus to Tackle ‘Undruggable’ Diseases
September 28, 2017
 · 
2 min read
Business
How Small Companies Can Navigate Partnerships In Medtech
September 22, 2017
 · 
1 min read
San Diego's Halozyme Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb and Roche
Business
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson
September 21, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
August 28, 2025
 · 
3 min read
Press Releases
Pendopharm® signs an exclusive distribution agreement with Neuraxpharm for PrBuccolam® in Canada and announces its approval by Health Canada
August 4, 2025
 · 
4 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
 · 
3 min read
Press Releases
Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana
July 30, 2025
 · 
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
 · 
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
 · 
8 min read
Press Releases
Mabwell Announces Novel Drug Technology License Agreement with Qilu Pharmaceutical for Albipagrastim alfa for Injection
June 27, 2025
 · 
5 min read
Press Releases
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
June 27, 2025
 · 
2 min read
Press Releases
Cyberlux Corporation Signs Strategic MoU with George Mason University to Accelerate Defense Innovation and Technology Commercialization
June 27, 2025
 · 
3 min read
Press Releases
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
June 26, 2025
 · 
5 min read
Press Releases
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
June 26, 2025
 · 
10 min read
Press Releases
CMUH and Shine-On Biomedical Lead Taiwan’s Push into Global Exosome-Based Precision Medicine
June 26, 2025
 · 
3 min read
Press Releases
KalVista Pharmaceuticals Enters into Licensing Agreement with Pendopharm to Commercialize Sebetralstat for HAE in Canada
June 26, 2025
 · 
4 min read
Press Releases
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
June 25, 2025
 · 
7 min read
Press Releases
Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.
June 25, 2025
 · 
5 min read
Press Releases
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
June 25, 2025
 · 
5 min read
Press Releases
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
 · 
5 min read
Press Releases
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
June 25, 2025
 · 
6 min read
Press Releases
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 25, 2025
 · 
5 min read
Press Releases
ONCare Alliance and Exigent Research Launch Groundbreaking Outpatient Bispecifics Program, Redefining Cancer Care Access, Support and Innovation
June 25, 2025
 · 
3 min read
Load More